Gainers
- Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) shares increased by 107.4% to $17.40 during Thursday's pre-market session. The market value of their outstanding shares is at $456.3 million. The most recent rating by Oppenheimer, on September 10, is at Outperform, with a price target of $14.00.
- ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) shares moved upwards by 16.6% to $51.65. The market cap stands at $6.5 billion. The most recent rating by Cantor Fitzgerald, on November 26, is at Overweight, with a price target of $70.00.
- DarioHealth, Inc. (NASDAQ:DRIO) stock rose 7.1% to $9.30. The market cap stands at $10.7 million.
- Innate Pharma, Inc. (NASDAQ:IPHA) shares rose 3.1% to $6.37. The market cap seems to be at $387.1 million.
- Genfit, Inc. (NASDAQ:GNFT) shares increased by 2.7% to $16.12. The market cap stands at $552.9 million.
- Canopy Growth, Inc. (NYSE:CGC) shares increased by 1.9% to $18.73. The market cap seems to be at $6.9 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
- Galapagos, Inc. (NASDAQ:GLPG) shares moved upwards by 1.7% to $209.17. The market cap seems to be at $11.3 billion. The most recent rating by Bank of America, on December 02, is at Neutral, with a price target of $199.00.
- OPKO Health, Inc. (NASDAQ:OPK) shares rose 1.2% to $1.66. The market cap seems to be at $945.1 million. The most recent rating by Piper Jaffray, on November 25, is at Overweight, with a price target of $2.50.
- Walgreens Boots Alliance, Inc. (NASDAQ:WBA) stock moved upwards by 1.1% to $59.59. The market value of their outstanding shares is at $48.8 billion. The most recent rating by JP Morgan, on October 23, is at Neutral, with a price target of $63.00.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- Sage Therapeutics, Inc. (NASDAQ:SAGE) shares plummeted 58.5% to $61.93 during Thursday's pre-market session. The market value of their outstanding shares is at $7.0 billion. The most recent rating by Canaccord Genuity, on November 13, is at Buy, with a price target of $218.00.
- Millendo Therapeutics, Inc. (NASDAQ:MLND) shares decreased by 20.2% to $6.19. The market cap seems to be at $97.1 million.
- Omeros, Inc. (NASDAQ:OMER) stock plummeted 11.2% to $13.54. The market cap seems to be at $784.4 million. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $34.00.
- Biocept, Inc. (NASDAQ:BIOC) shares plummeted 9.7% to $0.53. The market cap stands at $16.4 million.
- Akers Biosciences, Inc. (NASDAQ:AKER) stock plummeted 9.3% to $4.99. The market cap stands at $4.8 million.
- Avita Medical, Inc. (NASDAQ:RCEL) shares decreased by 3.0% to $8.30. The market value of their outstanding shares is at $788.9 million.
- Ardelyx, Inc. (NASDAQ:ARDX) shares fell 2.9% to $6.62. The market cap seems to be at $488.7 million. The most recent rating by SVB Leerink, on September 24, is at Outperform, with a price target of $9.00.
- Abeona Therapeutics, Inc. (NASDAQ:ABEO) stock decreased by 1.0% to $2.96. The market value of their outstanding shares is at $120.9 million.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.